Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 06 Feb 2026 for Phio Pharmaceuticals Corp..
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Jonathan E. Freeman: trading record in brief
This profile gathers the share dealings of Jonathan E. Freeman in Phio Pharmaceuticals Corp., where the filings describe the role as board member. We count 8 filings; the first trade dates from 1 August 2018 and the latest from 5 February 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 6 February 2026 came the latest disclosure, a share grant in Phio Pharmaceuticals Corp. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jonathan E. Freeman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
16,600 shares0Common Stock, $.0001 par valueSEC:0001683168-26-000811:0
14,700 shares0Common Stock, $.0001 par valueSEC:0001683168-25-006958:0
1,000 shares0Common Stock, $0.0001 par valueSEC:0001683168-24-006375:0
1,500 shares0Common stock, $0.0001 par valueSEC:0001209191-23-011937:0
10,000 shares0Common stock, $0.0001 par valueSEC:0001209191-22-010396:0
5 of 5 declarations
